Telix Pharmaceuticals
24/9 update: Gozellix has received US CMS transitional pass-through (TPT) status, effective from 1 Oct-25.
Transitional pass through (TPT) status allows for a separate payment in addition to payment for imaging in the outpatient setting.
22/9 update: Buy with a stop-loss at $14.10
Telix Pharmaceuticals
Telix Pharmaceuticals
Telix
Telix
Level 17 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
Send our ASX Research to your Inbox
Or start a free thirty day trial for our full service, which includes our ASX Research.